Hypercoagulability in ICU Patients With Coronavirus Disease 2019 With Respiratory Failure Results in Increased Prevalence of Venous Thromboembolic Disease

Chest. 2021 Mar;159(3):1208-1211. doi: 10.1016/j.chest.2020.09.081. Epub 2020 Sep 14.

Authors

Sarah A Long¹, Mohammad Y Tahboub², Jaime Palomino³, Ala L Alkhatib², Thomas P Kennedy², James Caridi¹, Joseph A Lasky⁴

Affiliations

¹ Department of Radiology, Tulane University School of Medicine, Tulane, LA.
² Section of Pulmonary/Critical Care, John W. Deming Department of Medicine, Tulane University School of Medicine, Tulane, LA.
³ Section of Pulmonary/Critical Care, John W. Deming Department of Medicine, Tulane University School of Medicine, Tulane, LA; Southeast Louisiana Veterans Health Care System, New Orleans, LA.
⁴ Section of Pulmonary/Critical Care, John W. Deming Department of Medicine, Tulane University School of Medicine, Tulane, LA. Electronic address: jlasky@tulane.edu.

No abstract available

MeSH terms

Anticoagulants / administration & dosage
COVID-19* / blood
COVID-19* / complications
COVID-19* / diagnosis
COVID-19* / physiopathology
Chemoprevention / methods
Critical Care / methods
Female
Fibrin Fibrinogen Degradation Products / analysis*
Health Services Needs and Demand
Heparin / administration & dosage*
Humans
Male
Mass Screening / methods*
Middle Aged
Outcome and Process Assessment, Health Care
Prevalence
Risk Assessment / methods
Risk Factors
Sensitivity and Specificity
Thrombophilia* / diagnosis
Thrombophilia* / virology
Venous Thromboembolism* / diagnosis
Venous Thromboembolism* / epidemiology
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants
Fibrin Fibrinogen Degradation Products
fibrin fragment D
Heparin